Global Immuno-Oncology Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 102

Published Date: 08 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Immuno-Oncology Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Immuno-Oncology Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Immuno-Oncology Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Immuno-Oncology Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Immuno-Oncology Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Immuno-Oncology Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immuno-Oncology Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immuno-Oncology Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly and Roche, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Immuno-Oncology Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Immune Checkpoint Inhibitors
    Monoclonal Antibodies
    Cytokine-Based Immunotherapy
    Cancer Vaccines
    CAR-T Cell Therapy

Market segment by Application
    Hospitals
    Ambulatory Surgical Center
    Others

Market segment by players, this report covers
    Amgen
    AstraZeneca
    Bristol-Myers Squibb
    Eli-Lilly
    Roche
    GlaxoSmithKline
    Janssen Biotech
    Merck
    Novartis
    Pfizer
    Sanofi
    Spectrum Pharmaceuticals
    Takeda

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immuno-Oncology Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-Oncology Treatment, with revenue, gross margin and global market share of Immuno-Oncology Treatment from 2018 to 2023.
Chapter 3, the Immuno-Oncology Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Immuno-Oncology Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-Oncology Treatment.
Chapter 13, to describe Immuno-Oncology Treatment research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Immuno-Oncology Treatment
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Immuno-Oncology Treatment by Type
        1.3.1 Overview: Global Immuno-Oncology Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Immuno-Oncology Treatment Consumption Value Market Share by Type in 2022
        1.3.3 Immune Checkpoint Inhibitors
        1.3.4 Monoclonal Antibodies
        1.3.5 Cytokine-Based Immunotherapy
        1.3.6 Cancer Vaccines
        1.3.7 CAR-T Cell Therapy
    1.4 Global Immuno-Oncology Treatment Market by Application
        1.4.1 Overview: Global Immuno-Oncology Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Ambulatory Surgical Center
        1.4.4 Others
    1.5 Global Immuno-Oncology Treatment Market Size & Forecast
    1.6 Global Immuno-Oncology Treatment Market Size and Forecast by Region
        1.6.1 Global Immuno-Oncology Treatment Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Immuno-Oncology Treatment Market Size by Region, (2018-2029)
        1.6.3 North America Immuno-Oncology Treatment Market Size and Prospect (2018-2029)
        1.6.4 Europe Immuno-Oncology Treatment Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Immuno-Oncology Treatment Market Size and Prospect (2018-2029)
        1.6.6 South America Immuno-Oncology Treatment Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Immuno-Oncology Treatment Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Immuno-Oncology Treatment Product and Solutions
        2.1.4 Amgen Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Amgen Recent Developments and Future Plans
    2.2 AstraZeneca
        2.2.1 AstraZeneca Details
        2.2.2 AstraZeneca Major Business
        2.2.3 AstraZeneca Immuno-Oncology Treatment Product and Solutions
        2.2.4 AstraZeneca Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 AstraZeneca Recent Developments and Future Plans
    2.3 Bristol-Myers Squibb
        2.3.1 Bristol-Myers Squibb Details
        2.3.2 Bristol-Myers Squibb Major Business
        2.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Product and Solutions
        2.3.4 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.4 Eli-Lilly
        2.4.1 Eli-Lilly Details
        2.4.2 Eli-Lilly Major Business
        2.4.3 Eli-Lilly Immuno-Oncology Treatment Product and Solutions
        2.4.4 Eli-Lilly Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Eli-Lilly Recent Developments and Future Plans
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche Immuno-Oncology Treatment Product and Solutions
        2.5.4 Roche Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Roche Recent Developments and Future Plans
    2.6 GlaxoSmithKline
        2.6.1 GlaxoSmithKline Details
        2.6.2 GlaxoSmithKline Major Business
        2.6.3 GlaxoSmithKline Immuno-Oncology Treatment Product and Solutions
        2.6.4 GlaxoSmithKline Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 GlaxoSmithKline Recent Developments and Future Plans
    2.7 Janssen Biotech
        2.7.1 Janssen Biotech Details
        2.7.2 Janssen Biotech Major Business
        2.7.3 Janssen Biotech Immuno-Oncology Treatment Product and Solutions
        2.7.4 Janssen Biotech Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Janssen Biotech Recent Developments and Future Plans
    2.8 Merck
        2.8.1 Merck Details
        2.8.2 Merck Major Business
        2.8.3 Merck Immuno-Oncology Treatment Product and Solutions
        2.8.4 Merck Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Merck Recent Developments and Future Plans
    2.9 Novartis
        2.9.1 Novartis Details
        2.9.2 Novartis Major Business
        2.9.3 Novartis Immuno-Oncology Treatment Product and Solutions
        2.9.4 Novartis Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Novartis Recent Developments and Future Plans
    2.10 Pfizer
        2.10.1 Pfizer Details
        2.10.2 Pfizer Major Business
        2.10.3 Pfizer Immuno-Oncology Treatment Product and Solutions
        2.10.4 Pfizer Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Pfizer Recent Developments and Future Plans
    2.11 Sanofi
        2.11.1 Sanofi Details
        2.11.2 Sanofi Major Business
        2.11.3 Sanofi Immuno-Oncology Treatment Product and Solutions
        2.11.4 Sanofi Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Sanofi Recent Developments and Future Plans
    2.12 Spectrum Pharmaceuticals
        2.12.1 Spectrum Pharmaceuticals Details
        2.12.2 Spectrum Pharmaceuticals Major Business
        2.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Product and Solutions
        2.12.4 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
    2.13 Takeda
        2.13.1 Takeda Details
        2.13.2 Takeda Major Business
        2.13.3 Takeda Immuno-Oncology Treatment Product and Solutions
        2.13.4 Takeda Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Takeda Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Immuno-Oncology Treatment Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Immuno-Oncology Treatment by Company Revenue
        3.2.2 Top 3 Immuno-Oncology Treatment Players Market Share in 2022
        3.2.3 Top 6 Immuno-Oncology Treatment Players Market Share in 2022
    3.3 Immuno-Oncology Treatment Market: Overall Company Footprint Analysis
        3.3.1 Immuno-Oncology Treatment Market: Region Footprint
        3.3.2 Immuno-Oncology Treatment Market: Company Product Type Footprint
        3.3.3 Immuno-Oncology Treatment Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Immuno-Oncology Treatment Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Immuno-Oncology Treatment Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Immuno-Oncology Treatment Consumption Value Market Share by Application (2018-2023)
    5.2 Global Immuno-Oncology Treatment Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Immuno-Oncology Treatment Consumption Value by Type (2018-2029)
    6.2 North America Immuno-Oncology Treatment Consumption Value by Application (2018-2029)
    6.3 North America Immuno-Oncology Treatment Market Size by Country
        6.3.1 North America Immuno-Oncology Treatment Consumption Value by Country (2018-2029)
        6.3.2 United States Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        6.3.3 Canada Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        6.3.4 Mexico Immuno-Oncology Treatment Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Immuno-Oncology Treatment Consumption Value by Type (2018-2029)
    7.2 Europe Immuno-Oncology Treatment Consumption Value by Application (2018-2029)
    7.3 Europe Immuno-Oncology Treatment Market Size by Country
        7.3.1 Europe Immuno-Oncology Treatment Consumption Value by Country (2018-2029)
        7.3.2 Germany Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        7.3.3 France Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        7.3.5 Russia Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        7.3.6 Italy Immuno-Oncology Treatment Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Immuno-Oncology Treatment Market Size by Region
        8.3.1 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Region (2018-2029)
        8.3.2 China Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        8.3.3 Japan Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        8.3.4 South Korea Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        8.3.5 India Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        8.3.7 Australia Immuno-Oncology Treatment Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Immuno-Oncology Treatment Consumption Value by Type (2018-2029)
    9.2 South America Immuno-Oncology Treatment Consumption Value by Application (2018-2029)
    9.3 South America Immuno-Oncology Treatment Market Size by Country
        9.3.1 South America Immuno-Oncology Treatment Consumption Value by Country (2018-2029)
        9.3.2 Brazil Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        9.3.3 Argentina Immuno-Oncology Treatment Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Country
        10.3.1 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Country (2018-2029)
        10.3.2 Turkey Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Immuno-Oncology Treatment Market Size and Forecast (2018-2029)
        10.3.4 UAE Immuno-Oncology Treatment Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Immuno-Oncology Treatment Market Drivers
    11.2 Immuno-Oncology Treatment Market Restraints
    11.3 Immuno-Oncology Treatment Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Immuno-Oncology Treatment Industry Chain
    12.2 Immuno-Oncology Treatment Upstream Analysis
    12.3 Immuno-Oncology Treatment Midstream Analysis
    12.4 Immuno-Oncology Treatment Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Immuno-Oncology Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Immuno-Oncology Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Immuno-Oncology Treatment Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Immuno-Oncology Treatment Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Amgen Company Information, Head Office, and Major Competitors
    Table 6. Amgen Major Business
    Table 7. Amgen Immuno-Oncology Treatment Product and Solutions
    Table 8. Amgen Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Amgen Recent Developments and Future Plans
    Table 10. AstraZeneca Company Information, Head Office, and Major Competitors
    Table 11. AstraZeneca Major Business
    Table 12. AstraZeneca Immuno-Oncology Treatment Product and Solutions
    Table 13. AstraZeneca Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. AstraZeneca Recent Developments and Future Plans
    Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
    Table 16. Bristol-Myers Squibb Major Business
    Table 17. Bristol-Myers Squibb Immuno-Oncology Treatment Product and Solutions
    Table 18. Bristol-Myers Squibb Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Bristol-Myers Squibb Recent Developments and Future Plans
    Table 20. Eli-Lilly Company Information, Head Office, and Major Competitors
    Table 21. Eli-Lilly Major Business
    Table 22. Eli-Lilly Immuno-Oncology Treatment Product and Solutions
    Table 23. Eli-Lilly Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Eli-Lilly Recent Developments and Future Plans
    Table 25. Roche Company Information, Head Office, and Major Competitors
    Table 26. Roche Major Business
    Table 27. Roche Immuno-Oncology Treatment Product and Solutions
    Table 28. Roche Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Roche Recent Developments and Future Plans
    Table 30. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 31. GlaxoSmithKline Major Business
    Table 32. GlaxoSmithKline Immuno-Oncology Treatment Product and Solutions
    Table 33. GlaxoSmithKline Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. GlaxoSmithKline Recent Developments and Future Plans
    Table 35. Janssen Biotech Company Information, Head Office, and Major Competitors
    Table 36. Janssen Biotech Major Business
    Table 37. Janssen Biotech Immuno-Oncology Treatment Product and Solutions
    Table 38. Janssen Biotech Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Janssen Biotech Recent Developments and Future Plans
    Table 40. Merck Company Information, Head Office, and Major Competitors
    Table 41. Merck Major Business
    Table 42. Merck Immuno-Oncology Treatment Product and Solutions
    Table 43. Merck Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Merck Recent Developments and Future Plans
    Table 45. Novartis Company Information, Head Office, and Major Competitors
    Table 46. Novartis Major Business
    Table 47. Novartis Immuno-Oncology Treatment Product and Solutions
    Table 48. Novartis Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Novartis Recent Developments and Future Plans
    Table 50. Pfizer Company Information, Head Office, and Major Competitors
    Table 51. Pfizer Major Business
    Table 52. Pfizer Immuno-Oncology Treatment Product and Solutions
    Table 53. Pfizer Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Pfizer Recent Developments and Future Plans
    Table 55. Sanofi Company Information, Head Office, and Major Competitors
    Table 56. Sanofi Major Business
    Table 57. Sanofi Immuno-Oncology Treatment Product and Solutions
    Table 58. Sanofi Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Sanofi Recent Developments and Future Plans
    Table 60. Spectrum Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 61. Spectrum Pharmaceuticals Major Business
    Table 62. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product and Solutions
    Table 63. Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Spectrum Pharmaceuticals Recent Developments and Future Plans
    Table 65. Takeda Company Information, Head Office, and Major Competitors
    Table 66. Takeda Major Business
    Table 67. Takeda Immuno-Oncology Treatment Product and Solutions
    Table 68. Takeda Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Takeda Recent Developments and Future Plans
    Table 70. Global Immuno-Oncology Treatment Revenue (USD Million) by Players (2018-2023)
    Table 71. Global Immuno-Oncology Treatment Revenue Share by Players (2018-2023)
    Table 72. Breakdown of Immuno-Oncology Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 73. Market Position of Players in Immuno-Oncology Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 74. Head Office of Key Immuno-Oncology Treatment Players
    Table 75. Immuno-Oncology Treatment Market: Company Product Type Footprint
    Table 76. Immuno-Oncology Treatment Market: Company Product Application Footprint
    Table 77. Immuno-Oncology Treatment New Market Entrants and Barriers to Market Entry
    Table 78. Immuno-Oncology Treatment Mergers, Acquisition, Agreements, and Collaborations
    Table 79. Global Immuno-Oncology Treatment Consumption Value (USD Million) by Type (2018-2023)
    Table 80. Global Immuno-Oncology Treatment Consumption Value Share by Type (2018-2023)
    Table 81. Global Immuno-Oncology Treatment Consumption Value Forecast by Type (2024-2029)
    Table 82. Global Immuno-Oncology Treatment Consumption Value by Application (2018-2023)
    Table 83. Global Immuno-Oncology Treatment Consumption Value Forecast by Application (2024-2029)
    Table 84. North America Immuno-Oncology Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 85. North America Immuno-Oncology Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 86. North America Immuno-Oncology Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. North America Immuno-Oncology Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. North America Immuno-Oncology Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 89. North America Immuno-Oncology Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 90. Europe Immuno-Oncology Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 91. Europe Immuno-Oncology Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 92. Europe Immuno-Oncology Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 93. Europe Immuno-Oncology Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 94. Europe Immuno-Oncology Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 95. Europe Immuno-Oncology Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 96. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 97. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 98. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 99. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 100. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Region (2018-2023) & (USD Million)
    Table 101. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Region (2024-2029) & (USD Million)
    Table 102. South America Immuno-Oncology Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 103. South America Immuno-Oncology Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 104. South America Immuno-Oncology Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 105. South America Immuno-Oncology Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 106. South America Immuno-Oncology Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 107. South America Immuno-Oncology Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 108. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 109. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 110. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 111. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 112. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 113. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 114. Immuno-Oncology Treatment Raw Material
    Table 115. Key Suppliers of Immuno-Oncology Treatment Raw Materials
List of Figures
    Figure 1. Immuno-Oncology Treatment Picture
    Figure 2. Global Immuno-Oncology Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Immuno-Oncology Treatment Consumption Value Market Share by Type in 2022
    Figure 4. Immune Checkpoint Inhibitors
    Figure 5. Monoclonal Antibodies
    Figure 6. Cytokine-Based Immunotherapy
    Figure 7. Cancer Vaccines
    Figure 8. CAR-T Cell Therapy
    Figure 9. Global Immuno-Oncology Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Immuno-Oncology Treatment Consumption Value Market Share by Application in 2022
    Figure 11. Hospitals Picture
    Figure 12. Ambulatory Surgical Center Picture
    Figure 13. Others Picture
    Figure 14. Global Immuno-Oncology Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Immuno-Oncology Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Immuno-Oncology Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Immuno-Oncology Treatment Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Immuno-Oncology Treatment Consumption Value Market Share by Region in 2022
    Figure 19. North America Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Immuno-Oncology Treatment Revenue Share by Players in 2022
    Figure 25. Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Immuno-Oncology Treatment Market Share in 2022
    Figure 27. Global Top 6 Players Immuno-Oncology Treatment Market Share in 2022
    Figure 28. Global Immuno-Oncology Treatment Consumption Value Share by Type (2018-2023)
    Figure 29. Global Immuno-Oncology Treatment Market Share Forecast by Type (2024-2029)
    Figure 30. Global Immuno-Oncology Treatment Consumption Value Share by Application (2018-2023)
    Figure 31. Global Immuno-Oncology Treatment Market Share Forecast by Application (2024-2029)
    Figure 32. North America Immuno-Oncology Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Immuno-Oncology Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 34. North America Immuno-Oncology Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Immuno-Oncology Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Immuno-Oncology Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 40. Europe Immuno-Oncology Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Immuno-Oncology Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Immuno-Oncology Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 48. Asia-Pacific Immuno-Oncology Treatment Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Immuno-Oncology Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Immuno-Oncology Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 57. South America Immuno-Oncology Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Immuno-Oncology Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Immuno-Oncology Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 62. Middle East and Africa Immuno-Oncology Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 66. Immuno-Oncology Treatment Market Drivers
    Figure 67. Immuno-Oncology Treatment Market Restraints
    Figure 68. Immuno-Oncology Treatment Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Immuno-Oncology Treatment in 2022
    Figure 71. Manufacturing Process Analysis of Immuno-Oncology Treatment
    Figure 72. Immuno-Oncology Treatment Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda

Related Reports

Global Immuno-Oncology Treatment Supply, Demand and Key Producers, 2023-2029

Global Immuno-Oncology Treatment Supply, Demand and Key Producers, 2023-2029

date 13 Feb 2023

date Medical Care

This report studies the global Immuno-Oncology Treatment demand, key companies, and key regions.

Global Immuno-Oncology Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Immuno-Oncology Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Immuno-Oncology Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Immuno-Oncology Treatment

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>